Skandinaviska Enskilda Banken Ab (Publ) Neogenomics Inc Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $245,070 - $435,330	21,000 Added 102.44%	41,500 $671,000
Q3 2023 Nov 09, 2023	BUY	$12.15 - $17.85 $249,075 - $365,925	20,500 New	20,500 $253,000
Q2 2022 Aug 10, 2022	BUY	$7.06 - $13.97 $114,929 - $227,417	16,279 Added 69.73%	39,626 $323,000
Q1 2022 May 11, 2022	SELL	$12.15 - $35.28 $140,830 - $408,930	-11,591 Reduced 33.18%	23,347 $284,000
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $292,744 - $369,058	7,027 Added 25.18%	34,938 $1.69 Million
Q2 2021 Aug 10, 2021	BUY	$36.62 - $51.69 $29,479 - $41,610	805 Added 2.97%	27,911 $1.26 Million
Q1 2021 May 14, 2021	SELL	$41.56 - $59.88 $8,602 - $12,395	-207 Reduced 0.76%	27,106 $1.31 Million
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $21,323 - $33,373	591 Added 2.21%	27,313 $1.47 Million
Q3 2020 Nov 12, 2020	BUY	$33.26 - $40.48 $868,717 - $1.06 Million	26,119 Added 4331.51%	26,722 $986,000
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $14,598 - $18,705	603 New	603 $19,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.83B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.